NCT06427304

Brief Summary

Tne aim purpose of this observational, multicentre and propective study is to determine the prevalence of cardiac amyloidosis in geriatric patients aged 80 years and older hospitalized within the last 12 months for heart failure with left ventricular hypertrophy (septum ≥ 12 mm) on echocardiography

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
637

participants targeted

Target at P75+ for all trials

Timeline
21mo left

Started Jul 2024

Typical duration for all trials

Geographic Reach
1 country

36 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress52%
Jul 2024Feb 2028

First Submitted

Initial submission to the registry

April 24, 2024

Completed
29 days until next milestone

First Posted

Study publicly available on registry

May 23, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

July 1, 2024

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 2, 2027

Expected
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 2, 2028

Last Updated

April 20, 2026

Status Verified

December 1, 2025

Enrollment Period

3 years

First QC Date

April 24, 2024

Last Update Submit

April 15, 2026

Conditions

Keywords

Cardiac amyloidosisHeart failure with left ventricular hypertrophyPositive bone scintigraphy

Outcome Measures

Primary Outcomes (1)

  • Assessment of the number of patients with cardiac amyloidosis according bon scintigraphy

    At inclusion

Secondary Outcomes (6)

  • Assessment of commorbidity risk according Charlson Comorbidity Index (CCI)

    At inclusion

  • Assessment of the degree of patient dependence according Katz Index of Independence in Activities of Daily Living (ADL)

    At inclusion

  • Measuring cognitive impairment according Mini-Mental State Examination (MMSE) score

    At inclusion

  • Estimating the probability of neuropathic pain according "DN4 Questionnaire"

    At inclusion

  • Assessment of physical frailty according Fried scale

    At inclusion

  • +1 more secondary outcomes

Eligibility Criteria

Age80 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with cardiac amyloidosis expressed by a positive bone scintigraphy.

You may qualify if:

  • Aged ≥ 80 years
  • Hospitalised for decompensation of heart failure in the last 12 months
  • Subjects with hypertrophy of the septum or left ventricle at cardiac echography (defined as ≥ 12 mm)
  • Subjects able to undergo a bone scintigraphy scan
  • Subjects willing to participate

You may not qualify if:

  • Subjects refusing to participate
  • Subjects admitted to palliative care unit.
  • Subjects under guardianship
  • Subjects with a definite diagnosis of cardiac amyloidosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (36)

Geriatric Department, Broca Hospital

Paris, IIe-de-France, 75013, France

RECRUITING

CHU Nantes

Nantes, Loire-Atlantique, 44000, France

RECRUITING

CHU Poitiers

Poitiers, New Aquitaine, 86000, France

RECRUITING

CHU Rouen, Charles Nicole hospital

Rouen, Normandy, 76000, France

RECRUITING

CHU Montpellier

Montpellier, Occitanie, 34090, France

RECRUITING

CHU Toulouse

Toulouse, Occitanie, 31300, France

RECRUITING

CHU Amiens Picardie

Amiens, 80000, France

RECRUITING

CHU Angers

Angers, 49100, France

RECRUITING

CHU Bordeaux

Bordeaux, 33000, France

RECRUITING

Centre Hospitalier de Carcassonne

Carcassonne, 11100, France

RECRUITING

Centre Hospitalier Intercommunal de Castres-Mazamet

Castres, 81100, France

RECRUITING

CHU Trousseau-Tours

Chambray-lès-Tours, 37170, France

RECRUITING

CHU Dijon

Dijon, 21000, France

RECRUITING

CHU Grenoble Alpes

Grenoble, 38700, France

RECRUITING

CHU Lille

Lille, 59000, France

RECRUITING

CHU Limoges

Limoges, 87000, France

RECRUITING

CHU Lyon

Lyon, 69002, France

RECRUITING

CHU Marseille

Marseille, 13005, France

RECRUITING

Clinique du Millénaire-Montpellier

Montpellier, 34000, France

RECRUITING

CHRU Nancy

Nancy, 54000, France

RECRUITING

CHU Nice

Nice, 06000, France

RECRUITING

Hôpital Privé Gériatrique LES SOURCES-Nice

Nice, 06100, France

RECRUITING

CHU Orléans

Orléans, 45100, France

RECRUITING

CHU Rennes

Rennes, 35000, France

RECRUITING

CHRU Tours-Bretonneau Hospital

Tours, 37000, France

RECRUITING

Clinique Saint Joseph Trelaze

Trélazé, 49800, France

RECRUITING

Médipôle Hôpital Mutualiste Villeurbanne

Villeurbanne, 69100, France

RECRUITING

Ambroise Paré Hospital

Boulogne-Billancourt, Île-de-France Region, 92100, France

RECRUITING

Corentin Celton Hospital

Issy-les-Moulineaux, Île-de-France Region, 92130, France

NOT YET RECRUITING

Charles Foix Hospital

Ivry-sur-Seine, Île-de-France Region, 94200, France

RECRUITING

Emile Roux Hospital

Limeil-Brévannes, Île-de-France Region, 94450, France

RECRUITING

GH Sud Ile-de-France

Melun, Île-de-France Region, 77000, France

RECRUITING

Lariboisière Hospital

Paris, Île-de-France Region, 75010, France

RECRUITING

Saint Joseph Hospital

Paris, Île-de-France Region, 75014, France

RECRUITING

Europeen Georges Pompidou Hospital

Paris, Île-de-France Region, 75015, France

RECRUITING

Bretonneau Hospital

Paris, Île-de-France Region, 75018, France

RECRUITING

MeSH Terms

Conditions

Amyloid Neuropathies, Familial

Condition Hierarchy (Ancestors)

Heredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesNervous System DiseasesAmyloid NeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesAmyloidosis, FamilialMetabolism, Inborn ErrorsMetabolic DiseasesNutritional and Metabolic DiseasesAmyloidosisProteostasis Deficiencies

Study Officials

  • Olivier Hanon, MD PhD

    Geriatric Department, Broca hospital

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 24, 2024

First Posted

May 23, 2024

Study Start

July 1, 2024

Primary Completion (Estimated)

July 2, 2027

Study Completion (Estimated)

February 2, 2028

Last Updated

April 20, 2026

Record last verified: 2025-12

Locations